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Abstract
Background: Previous studies of network properties of human disease genes have mainly focused on monogenic diseases
or cancers and have suffered from discovery bias. Here we investigated the network properties of complex disease genes
identified by genome-wide association studies (GWAs), thereby eliminating discovery bias.
Principal findings: We derived a network of complex diseases (n=54) and complex disease genes (n=349) to explore the
shared genetic architecture of complex diseases. We evaluated the centrality measures of complex disease genes in
comparison with essential and monogenic disease genes in the human interactome. The complex disease network showed
that diseases belonging to the same disease class do not always share common disease genes. A possible explanation could
be that the variants with higher minor allele frequency and larger effect size identified using GWAs constitute disjoint parts
of the allelic spectra of similar complex diseases. The complex disease gene network showed high modularity with the size
of the largest component being smaller than expected from a randomized null-model. This is consistent with limited sharing
of genes between diseases. Complex disease genes are less central than the essential and monogenic disease genes in the
human interactome. Genes associated with the same disease, compared to genes associated with different diseases, more
often tend to share a protein-protein interaction and a Gene Ontology Biological Process.
Conclusions: This indicates that network neighbors of known disease genes form an important class of candidates for
identifying novel genes for the same disease.
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Introduction
Systems Biology based approaches of studying human genetic
diseases have brought in a shift in the paradigm of elucidating
disease mechanisms from analyzing the effects of single genes to
understanding the effect of molecular interaction networks. Such
networks have been exploited to find novel candidate genes, based
on the assumption that neighbors of a disease-causing gene in a
network are more likely to cause either the same or a similar
disease [1–14]. Initial studies investigating the network properties
of human disease genes were based on cancers and revealed that
up-regulated genes in cancerous tissues were central in the
interactome and highly connected (often referred to as hubs)
[1,2]. A subsequent study based on the human disease network
and disease gene network derived from the Online Mendelian
Inheritance in Man (OMIM) demonstrated that the products of
disease genes tended (i) to have more interactions with each other
than with non-disease genes, (ii) to be expressed in the same tissues
and (iii) to share Gene Ontology (GO) terms [8]. Contradicting
earlier reports, this latter study demonstrated that the non-essential
human disease genes showed no tendency to encode hubs in the
human interactome. A more recent report that evaluated the
network properties of disease genes showed that genes with
intermediate degrees (numbers of neighbors) were more likely to
harbor germ-line disease mutations [12]. However, interpretation
of this dataset might not be applicable to complex disease genes
since 97% of the disease genes were monogenic. Despite this
reservation, both the latter studies found a functional clustering of
disease genes. Another concern is that the above studies could be
confounded by discovery bias, in other words these disease genes
were identified based on previous knowledge. By contrast,
Genome Wide Association studies (GWAs) do not suffer from
such bias [15].
In this study, we have derived networks of complex diseases and
complex disease genes to explore the shared genetic architecture of
complex diseases studied using GWAs. Further, we have evaluated
the topological and functional properties of complex disease genes
in the human interactome by comparing them with essential,
monogenic and non-disease genes. We observed that diseases
belonging to the same disease class do not always show a tendency
to share common disease genes; the complex disease gene net-
work shows high modularity comparable to that of the human
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e8090interactome; complex disease genes associated with same disease
more often tend to share a protein-protein interaction (PPI) and
GO biological process in comparison to the genes associated with
different diseases. We demonstrate that complex disease genes are
less central to the essential and monogenic disease genes in the
molecular interaction network. Our results support the assumption
that novel candidate genes might be identified among the network
neighbors of known complex disease genes.
Methods
Data Sources
We obtained the list of complex human disease associated genes
identified by GWAs (Table S1) from ‘A catalog of published
genome-wide association studies’ (retrieved on March 23, 2009)
[16]. The complex disease genes catalogued in this database have
SNPs published with a p-value less than 1E-5. The complex disease
genes dataset contained 349 genes that were implicated in 54
complex diseases. Disease classes of these diseases were identified
using MeSH (Medical Subject Headings) terms. We retrieved a list
of monogenic disease genes (n=738) from the compendium
compiled by Jimenez-Sanchez et al [17]. Essential genes were
definedaspreviouslydescribed[8].Briefly,a listofhumanorthologs
of mouse genes that resulted in a lethal phenotype inembryonic and
postnatal stages upon knockout was obtained from the Mouse
Genome database [18]. Next, complex and monogenic disease
genes were removed from that list resulting in 1986 essential genes.
To construct a human interactome, we obtained 35,021 protein-
protein interactions (PPIs) pertaining to 9462 proteins from the
Human Protein Reference Database (HPRD) database (release 7)
[19], as it is known to be one of the most reliable databases for PPI
data [20]. Non-essential genes without any disease associations and
with interactions in HPRD were considered as non-disease genes
(n=6659).
Construction of Complex Disease and Complex Disease
Gene Networks
We constructed two separate networks from the compendium of
human complex diseases and their associated genes. In the complex
disease network (CDN), the nodes of the network are diseases and
twodiseaseswereconnectediftheysharedanassociated gene;inthe
complex disease gene network (CGN) nodes are genes and a link
represents two genes associated with the same disease. To
investigate how the topology of CGN differed from random null
model networks we randomly rewired the links between genes 1000
times, while keeping degrees constant. P-values for assortativity and
modularity of networks have been estimated as the ratio of
randomized models with a higher value of the corresponding
topological parameter than that of the real networks. To investigate
if the CGN shared topological features with the interactome we
applied the same method to the interactome data. (A detailed
description is given in Supplementary Material S1.) Such rewiring
methods need large networks to be interpretable. Due to its small
numberof edges,we avoidedthese methods foranalyzingtheCDN.
Topological and Functional Properties of Complex
Disease Genes in Human Interactome
In many types of networks, including gene networks, one can
assume that the importance of a node (for example the likelihood
of causing a disease) is correlated with centrality. There is,
however, not only one way of measuring network centrality; rather
there are different types of measures trying to capture different
aspects of the concept. We measure three different centrality
quantities — degree, closeness and eccentricity. Closeness is defined as
the reciprocal average distance (number of links in the shortest
path) to every other node — a node with high closeness is thus, on
average, close in graph distance to the other nodes. The
eccentricity of a node is the distance to the farthest reachable
other node in a network, thus focusing on a maximal property
where closeness focus on an average. We compare these
topological measures between different classes of genes by
Mann–Whitney U tests.
To determine functional similarity among genes causing the
same disease compared to genes causing different diseases, we used
the Biological Process category of Gene Ontology classification.
We also determined the enriched terms among our complex
disease genes compared to all genes listed in Entrez database,
using the Bioconductor package TopGO [21].
Results
Complex Diseases Network (CDN)
Our complex disease network (CDN) consisted of 54 nodes and
41edges.Most ofthenodeswereisolateswithonly26havingatleast
one edge (Figure 1A). The node size in Fig. 1A corresponds to the
number of genes associated with eachdisease. The differencesin the
node sizes could effectively represent the differences in the allelic
architecture among these common complex diseases. Ideally,
GWAs capture association of variants with a considerably higher
minor allele frequency (MAF) and large effect sizes (referred
hereafteras high-profile variants).This could mean that diseases like
type 1 diabetes and multiple sclerosis (with 36 disease genes each)
may involve a larger number of genes with high-profile variants
than Parkinson’s disease andrestless legs syndromethat involve only
5 genes. It is tempting to speculate that the allelic architecture of
diseases with fewer associated genes from GWA studies might have
an overrepresentation of variants with relatively lesser MAF, or
more modest allele effect sizes, or both. There were 17 diseases with
only one associated gene, possibly questioning the role of high-
profile variants in these diseases. Strikingly, attention deficit
hyperactivity disorder and conduct disorder had 33 associated
genes but belonged to an isolated cluster of only three nodes. This
is a clear indication of different underlying pathophysiological
mechanisms for these diseases compared to other diseases in our
dataset. Furthermore, breast cancer (with 12 genes) and chronic
lymphocytic leukemia (with 8 genes) did not have any edge.
Notably, the number of studies performed and the sample size
considered can also affect the number of genes identified and thus
also our interpretations. An increase in the number of studies and
the sample size might lead to the identification of new genes and
hence expansion of CDN and CGN.
Most intriguingly, diseases perceived to share pathophysiolog-
ical mechanisms (different forms of cancer, Type 1 and Type 2
diabetes, neurodegenerative diseases) were not directly connected
in the CDN. In fact, the different cancer types did not show any
overlapping genes. Moreover, even though type 1 and type 2
diabetes were both part of the same component, they were only
linked indirectly with Crohn’s disease acting as a connecting link.
Links between mental and metabolic diseases in the CDN
emphasize the emerging concept of convergent mechanisms
underlying these classes of complex diseases [22]. The modular
nature of human genetic diseases has generated a lot of enthusiasm
of an easy way of predicting new disease genes for phenotypically
similar diseases [23]. However, the CDN obtained from GWAs
results did not provide evidence for modularity of phenotypically
similar genetic diseases. This suggests that high-profile variants
often constitute disjoint parts of the allelic spectra of phenotyp-
ically similar complex diseases.
Network Properties - GWA Genes
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The CGN consisted of 349 genes (nodes) and 3440 edges
(Fig. 1B). In the CGN 349 nodes were connected to at least to one
other gene and 214 belonged to the giant component. Very few
genes were associated with multiple diseases (grey-colored in
Fig. 1B). HLA-DQA1, HLA-DRB1, CDKN2A, CDKN2B, IL23R and
HLA-E genes showed an association with more than two diseases.
Most of the genes that were associated with more than one disease
were inflammatory; exceptions being CDKN2A and CDKN2B that
were involved in proliferation. Interestingly genes involved in
cancers and certain nervous system diseases were rarely associated
with any other diseases; genes associated with one type of cancer
were not associated with other types. Given that the link between
two genes represent their association to the same disease it would
be interesting to evaluate the combined effect of their correspond-
ing variants on the disease susceptibility. Contrary to the
candidate-gene-based association studies, GWAs effectively over-
come spurious associations, emphasizing that the genes associated
with multiple diseases may possibly elevate the risk for all the
diseases they are implicated with.
Topological Properties of Complex Disease Genes in
Human Interactome
We obtained PPIs from HPRD and constructed a molecular
interaction network. One of the network measures we use to
quantify this data with is the assortativity. This quantity measures
the tendency for nodes with similar magnitude of degrees to be
connected by an edge. This determines whether the nodes of large
degrees are primarily linked to low-degree vertices or if low- and
high-degree vertices are typically connected. Technically, the
Figure 1. Networks of complex diseases and complex disease genes. A) Complex Disease Network (CDN). Each node is a complex disease
studied in GWAs with the link representing sharing of disease genes. The color of the nodes corresponds to disease class as identified using MeSH
(Medical Subject Headings) terms as given on the right side. Notably, complex diseases are hard to define using single MeSH term. The node size
refers to the number of associated genes identified. Diseases with most number of associated genes identified through GWAs are listed on the right
side with the numbers in the parenthesis indicating the number of associated genes. B) Complex Disease Gene Network (CGN): Each node represents
a gene and connections between two genes represent their association with the same disease. The node size refers to the number of diseases a gene
is associated with. Genes associated with many diseases are listed on the top right side with the number of diseases they are implicated with, in the
parenthesis. A node (highlighted in gray) each in lung cancer and Alzheimer’s disease gene cluster are singular associations in idiopathic pulmonary
fibrosis and narcolepsy respectively.
doi:10.1371/journal.pone.0008090.g001
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either side of an edge, over the set of all edges. (Assortativity is
further described in Supplementary Material S1.) We observed a
negative assortativity of the human interactome; it was, however,
larger than the randomized networks (–0.05 and –0.12 respec-
tively; P,0.001). This means that, given the degrees of the
interactome, it was actually wired with a bias towards degrees of
similar magnitude being connected. Note, however, given that the
range of possible r-values for a graph constrained to a specific set of
degrees typically varies about 1.5 units [24], thus the magnitude of
r for the real and rewired networks were close. So, even though the
P-value indicated that the real r was significantly larger than our
null-model, the indicated tendency could have been stronger,
given the basic constraints of the null-model. The modularity (the
tendency for the network to be divisible into dense regions that are
sparsely interconnected, see Supplementary Material S1) was
significantly larger than the randomized null model (0.53 and 0.32
respectively; P,0.001), which supported a modular organization
of the PPI network. The overlap (see Supplementary Material S1)
between annotated diseases and network clusters had a z-score of
3.960.1, meaning that the network clusters separated the disease
genes so that genes belonging to the same category of disease were
significantly more likely to belong to the same network cluster than
expected by chance. The giant component of the human
interactome consisted of 9045 nodes in comparison to 9281.6
nodes in the random network (P,0.001). This suggested that the
human CGN shares topological similarities with that of the human
interactome.
We examined the topological properties of the complex disease
genes in the human interactome by comparing them with that of
monogenic disease genes and non-disease genes. We observed that
the degrees of complex disease genes were significantly lower than
those of monogenic disease genes (average degrees are 9.5 and
13.3 respectively; P=6.4610
24). Differences in closeness provided
suggestive significance between these two groups (average values
0.24 and 0.25 respectively; P=0.05) while complex disease genes
had higher average eccentricity (9.8) compared to monogenic
disease genes (9.6; P=7.3610
24). Comparisons with non-disease
genes revealed that complex disease genes had higher degree,
closeness and eccentricity (P=6.3610
24; 0.03 and 0.008 respec-
tively). The respective average values for non-disease genes were
5.8, 0.23 and 9.9. The relative frequency of each class of genes in
each interval of degree, closeness and eccentricity explicitly
demonstrated this (Fig. 2 panels A, B and C respectively). From
Figure2. Comparative distribution oftopological measures (A) Degree, (B) Closeness and (C). Eccentricity among monogenic disease genes,
complex disease genes and non-disease genes in human interactome. The co-ordinates on the Y-axis indicate the relative frequency of each of the above
mentioned classes in a given bin with the error bars indicating the fraction of genes in each bin for each class of genes. For example, monogenic disease
genes are over-represented in the bin of 0.30, for closeness while closeness values for most of the genes in each class lie in the interval of 0.21–0.25.
doi:10.1371/journal.pone.0008090.g002
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compared to the monogenic disease genes and occupy an
intermediate niche between the monogenic disease genes and
non-disease genes. However, knowledge bias associated with
human interactome may affect the outcome of such comparisons.
Higher network connectivity of essential genes has already been
well documented [25]. Our results confirmed this observation,
highlighting that essential genes have higher degree and closeness




24 respectively). With the
current understanding of the human interactome and the results
presented here, the centrality of gene classes can be ordered as
essential genes (being the most central), monogenic disease genes,
complex disease genes and non-disease genes (being the most
peripheral). Moving from the center to the periphery is thus
moving from lethality, via disease to negligible effect of variations
and thus reflects importance of functionality of the encoded
proteins. For mutations in individual genes to be sufficient to
manifest clinical phenotypes they should occur in less central
regions of the interactome which do not affect the survival. That
complex disease genes are relatively peripheral accentuates that
variations in these genes are essential, but not sufficient, to result in
a disease phenotype, which aid their maintenance and perpetu-
ation in a population.
Functional Properties of Complex Disease Genes in
Human Interactome
Genes associated with the same disease tended to share a PPI
more often than genes associated with different diseases
(P=5.1610
25). Effectively, the average distance between genes
causing the same disease was significantly lower than the average
distance between genes associated with different diseases
(P=2.7610
25). We observed a strong tendency for genes causing
the same disease, compared to genes associated different diseases,
to share the same GO term (13.3% and 8.9% respectively;
P=1.9610
212). There seemed to be an overrepresentation of
inflammatory genes among all the disease genes compared to all
known genes, as can be seen in table 1. This might indicate that
the common complex diseases pertinently involve inflammatory
responses. Notably, such an observation may also result from the
kind of diseases studied using GWAs so far.
Discussion
In conclusion, here we have derived networks for complex
diseases and complex disease genes based on GWAs, most of
which have analyzed Caucasian population. With the information
from GWAs done on other populations, we expect that CGN and
CDN would expand. Nevertheless, GWAs mostly done on
Caucasians adds strength to the analysis provided here, as these
networks are derived from a homogenous population with isogenic
background. The advantage of using GWAs data is that complex
disease genes, unlike genes listed in OMIM, are identified without
discovery bias. However, the results presented here are to be
interpreted with caution as the genes considered here are
identified to be associated with complex diseases and less is
known about their role in disease causality. Other possible
confounders include the kind of common complex diseases studied
using GWAs and the knowledge-based bias associated with the
human interactome. Notably, GWAs are empowered to track
disease association of high-profile variants (higher MAF and/or
high allele-effect size). So, the results presented here do not
account for variants with modest allele effect size. The complex
disease genes exhibited significantly different topological features
compared to the monogenic disease genes. We, therefore, surmise
that genes in the network neighborhood of complex disease genes
should be prioritized in predicting new complex disease gene
candidates. As the number of diseases studied using GWAs
increases, improving the resolution of the CDN and CGN, we
expect a better comprehension of the complex diseases, co-
morbidities and the underlying mechanisms.
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